Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
about
Determinants of relapse periodicity in Plasmodium vivax malariaVaccines for preventing malaria (SPf66)A review of malaria vaccine clinical projects based on the WHO rainbow tableMerozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaA week in the life of a travel clinic.IMPIPS: the immune protection-inducing protein structure concept in the search for steric-electron and topochemical principles for complete fully-protective chemically synthesised vaccine developmentPredicting key malaria transmission factors, biting and entomological inoculation rates, using modelled soil moisture in Kenya.Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border.Characterization of protective epitopes in a highly conserved Plasmodium falciparum antigenic protein containing repeats of acidic and basic residues.Development of vaccines against human parasitic diseases: tools, current status and perspectives.Progress toward a malaria vaccine: efficient induction of protective anti-malaria immunity.Towards a blood-stage vaccine for malaria: are we following all the leads?Selection and quantification of infection endpoints for trials of vaccines against intestinal helminthsReader technique as a source of variability in determining malaria parasite density by microscopyMalaria in the post-genomics era: light at the end of the tunnel or just another train?Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines.The immunological challenge to developing a vaccine to the blood stages of malaria parasites.Medicinal application of long synthetic peptide technology.Vaccination against malaria with live parasites.Clinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: a methodological review.Designing a malaria vaccine.A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervalsMurine infection models for vaccine development: the malaria example.Suppression of vaccine responses by malaria: insignificant or overlooked?Towards the development of a fully protective Plasmodium falciparum antimalarial vaccine.An evidence-based systematic review of vitamin A by the natural standard research collaboration.Serological responses of Gambian children to immunization with the malaria vaccine SPf66.Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine.Human malaria: segregation analysis of blood infection levels in a suburban area and a rural area in Burkina Faso.A primary malarial infection is composed of a very wide range of genetically diverse but related parasites.Malaria vaccine: roadblocks and possible solutions.Humoral immune responses during a malaria vaccine trial in Tanzanian infants.Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children.A Large Size Chimeric Highly Immunogenic Peptide Presents Multistage Plasmodium Antigens as a Vaccine Candidate System against Malaria.Making malaria research bite.Acceptability of a herd immunity-focused, transmission-blocking malaria vaccine in malaria-endemic communities in the Peruvian Amazon: an exploratory study.
P2860
Q17485692-347DD98C-1C16-4D07-AC5D-31C011B5DA89Q21032526-890DC53E-E4F5-4AFC-B4F2-2B1F5F528E95Q21034112-9D062F73-CDF5-42BC-954D-9AD0032865FAQ26772878-A0AE8504-B8C6-4A25-B040-75CB8DC5085AQ27477861-363952BD-4D5C-43FE-A9B2-6F0829B8C80EQ30373743-3F92E161-CCE2-441F-AA1A-D638973C7577Q31977961-8443A27A-D1E8-44E1-8EA0-345FD2ADD79AQ33754684-DB9C5CE9-FAFF-4F90-8597-2CB2AC873400Q33755404-AB3E44E2-2829-4457-8967-393ACCD93235Q34074704-A34ACD0E-6509-426E-B9B2-41C95153060BQ34280935-FF0F93FA-21F3-41B2-A905-97BB4F2B7221Q34572160-DD691E7F-711F-495A-A498-C6E7A681F4C1Q34978256-ADD0527A-4B33-465F-982E-0444D3025522Q35238290-540BCD03-5B74-4780-A928-618AB02D7448Q35522550-6848465B-ACA7-4E10-BC5E-7866B6C25FE2Q35862464-0D270DEC-CD38-49D2-804C-23109806D7C7Q35884247-EF87EA34-56B0-423D-92BE-EAC391E18275Q35907030-0FDB7A8F-BD66-4FD4-9265-B80370563DBCQ36600336-D300727E-079B-449F-A1DD-A00E752FA130Q37107195-0E63168E-6FD9-4A90-9471-F94BBD2D0F28Q37209392-EE3277E5-A514-4E08-A68B-D1C0D47519C0Q37294887-C4B069FE-EDA9-4D3E-BD2E-0E8E939F402FQ37478246-6A54E4F0-7267-4352-B7D2-EE75BBA21C70Q37724859-0DBE9BB4-ACE5-4402-8608-B4EAF5A3468EQ38059750-CC8CAB62-CB1D-4644-8DF7-781CD41188E8Q38060232-27B0B320-4CBF-43D6-A20A-8F49BF683BF1Q39247939-5591F5DA-98B8-47C4-B040-511627AFC5FCQ39372910-4E560FB9-DD3B-4696-9AEC-6AA0BAB7CCB6Q39474856-34D4D202-7CB0-4339-9D8C-8474A685A27CQ39803842-6EB98E53-54E6-40D9-BCA8-82CEFAFA2532Q40847091-8E1EA986-8BD1-4C3C-B14F-6799D8950A33Q43951508-625128EB-BCD9-41B2-B46E-D635654909D1Q43952848-E1AAFA21-F5C1-41CF-B18F-BAC5390DE753Q47177933-F24C9335-9E55-4242-BBC3-D638039B169AQ48035088-FF1DDB31-F8E3-4D4D-9474-D128397ECF8BQ55104120-0B8CE968-0939-4DDC-B4E6-2AC66D6074AB
P2860
Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Randomised double-blind placeb ...... 6 Malaria Vaccine Trial Group.
@ast
Randomised double-blind placeb ...... 6 Malaria Vaccine Trial Group.
@en
Randomised double-blind placeb ...... 6 Malaria Vaccine Trial Group.
@nl
type
label
Randomised double-blind placeb ...... 6 Malaria Vaccine Trial Group.
@ast
Randomised double-blind placeb ...... 6 Malaria Vaccine Trial Group.
@en
Randomised double-blind placeb ...... 6 Malaria Vaccine Trial Group.
@nl
prefLabel
Randomised double-blind placeb ...... 6 Malaria Vaccine Trial Group.
@ast
Randomised double-blind placeb ...... 6 Malaria Vaccine Trial Group.
@en
Randomised double-blind placeb ...... 6 Malaria Vaccine Trial Group.
@nl
P2093
P50
P921
P1433
P1476
Randomised double-blind placeb ...... 6 Malaria Vaccine Trial Group.
@en
P2093
C Luxemburger
D G Heppner
D M Gordon
J C Sadoff
T Chongsuphajaisiddhi
P304
P356
10.1016/S0140-6736(96)04465-0
P407
P577
1996-09-01T00:00:00Z